Follicular Lymphoma
News
Anticancer drugs might promote lymphoma
Agents that inhibit tumor growth by targeting the regulatory protein CDK4 might actually promote the growth of B-cell lymphomas, a new study...
News
Idelalisib more effective in CLL, iNHL than MCL
Credit: FDA Results of a phase 1 study suggest the PI3K delta inhibitor idelalisib can produce durable responses in certain patients with relapsed...
Conference Coverage
RIT can improve transplant outcomes in NHL, CLL
Ryan Cassaday, MD, of the University of Washington in Seattle, noted that RIT-augmented NMAT can produce long-term remissions in patients with...
News
Team identifies mutations that may drive FL
Genetic profiling has provided a clearer picture of follicular lymphoma (FL) development and progression, according to research published in...
News
Immune microenvironment linked to prognosis of follicular lymphoma
Major finding: The combination of the number of PMCH- and NAMPT-expressing cells in the interfollicular area plus the interfollicular-to-...
News
Bendamustine-Rituximab Doubles Progression-Free Survival in Indolent Lymphomas
News
The Oncology Report Guide to Cancer Drugs and Devices in 2011
News
Is the US running too many T-cell lymphoma trials?
SAN FRANCISCO—The US currently has 284 open clinical trials enrolling patients with T-cell lymphomas, a fact that is actually detrimental to this...
Conference Coverage
Pregnant Women With Lymphoma Can Have Good Outcomes
Major Finding: Among women with lymphomas diagnosed during pregnancy, the 3-year progression-free survival rates were 76% in women who underwent...
News
Obinutuzumab Equals Rituximab in Relapsed Indolent NHL
Major Finding: The overall investigator-rated response rate among patients with relapsed CD20+ follicular lymphoma assigned to obinutuzumab was 44...